1-3 of 3
Deborah A. Dillon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation

Nam Woo Cho, Sophia M. Guldberg, Barzin Y. Nabet, Jie Zeng Yu, Eun Ji Kim, Kamir J. Hiam-Galvez, Jacqueline L. Yee, Rachel DeBarge, Iliana Tenvooren, Naa Asheley Ashitey, Filipa Lynce, Deborah A. Dillon, Jennifer M. Rosenbluth, Matthew H. Spitzer
Journal: Cancer Immunology Research
Cancer Immunol Res OF1–OF16.
https://doi.org/10.1158/2326-6066.CIR-24-0416
Published: 06 January 2025
View article titled, T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation
Open the PDF for T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation in another window
Includes: Supplementary data
Journal Articles

Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer

Carlos R. Gil Del Alcazar, Anne Trinh, Maša Alečković, Ernesto Rojas Jimenez, Nicholas W. Harper, Michael U.J. Oliphant, Shanshan Xie, Ethan D. Krop, Bethlehem Lulseged, Katherine C. Murphy, Tanya E. Keenan, Eliezer M. Van Allen, Sara M. Tolaney, Gordon J. Freeman, Deborah A. Dillon, Senthil K. Muthuswamy, Kornelia Polyak
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (6): 680–697.
https://doi.org/10.1158/2326-6066.CIR-21-0804
Published: 03 June 2022
View article titled, Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Open the PDF for Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing the antitumor potential of TAMs

Anita K. Mehta, Emily M. Cheney, Jessica A. Castrillon, Jia-Ren Lin, Mateus de Oliveira Taveira, Christina A. Hartl, Nathan T. Johnson, William M. Oldham, Marian Kalocsay, Sarah A. Boswell, Olmo Sonzogni, Constantia Pantelidou, Brett P. Gross, Shawn Johnson, Deborah A. Dillon, Sandro Santagata, Judy E. Garber, Nadine Tung, Elizabeth A. Mittendorf, Gerburg M. Wulf, Geoffrey I. Shapiro, Peter K. Sorger, Jennifer L. Guerriero
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): A105.
https://doi.org/10.1158/2326-6074.TUMIMM19-A105
Published: 02 March 2020
View article titled, Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing the antitumor potential of TAMs